Diabetes Study Needs Participants

A study at NIH is recruiting healthy African Americans and African-born individuals to better understand diabetes and heart disease risk in Black populations. If you are African American or African-born Black between ages 18 and 70, you may be eligible to enroll. The study has two visits and compensation is provided. To see if you are eligible, call the Clinical Center Office of Patient Recruitment at 866-444-2214 (TTY users dial 711), ccopr@nih.gov. Ask for study 99-DK-0002. Online: https://go.nih.gov/ozorcOJ.  

Study on Hearing Loss Seeks Volunteers

Individuals undergoing cisplatin therapy are at risk for developing significant, permanent hearing loss. Doctors at NIDCD are investigating the effectiveness of atorvastatin (a drug used to lower “bad” cholesterol and fats such as LDL and triglycerides, and increase “good” cholesterol, HDL) at reducing the incidence of hearing loss in patients treated with cisplatin for head and neck cancer. Doctors will compare hearing changes by providing a daily dose of atorvastatin or a placebo to potential volunteers undergoing cisplatin-based chemotherapy to treat head and neck cancer. For more information, call 866-444-2214; ccopr@nih.gov, TTY users dial 711). Online: https://go.usa.gov/xFY69. Refer to study #21-DC-0002.

Study on Sickle Cell and Gene Variation Recruits Volunteers

Dr. Swee Lay Thein, along with a team from NHLBI, is conducting research on the relationship between sickle cell disease and specific variations of certain genes. The study involves analysis of fluid and cells obtained from blood, tissue and other sources. Collected samples will be used to investigate the role of genetic risk factors in sickle cell disease. If you are interested in participating or have any inquiries, contact the Clinical Center Office of Patient Recruitment at 866-444-2214 (TTY users dial 711) or ccopr@nih.gov. Refer to study #04-H-0161. For more information about the study online, go to https://go.nih.gov/6ddLFWJ.